Pacific Biosciences of California, Inc. (PACB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 1.5600 |
| Open | 1.5600 |
| Bid | 1.4500 x 7200 |
| Ask | 1.4800 x 7200 |
| Day's Range | 1.4500 - 1.6500 |
| 52 Week Range | 1.2500 - 14.5500 |
| Volume | |
| Avg. Volume | 9,765,237 |
| Market Cap | 393.889M |
| Beta (5Y Monthly) | 1.83 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2100 |
| Earnings Date | Apr 30, 2024 - May 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.08 |
ZacksPacific Biosciences (PACB) Upgraded to Buy: Here's What You Should Know
Pacific Biosciences (PACB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Simply Wall St.Pacific Biosciences of California, Inc. (NASDAQ:PACB) Analysts Just Slashed This Year's Revenue Estimates By 18%
Market forces rained on the parade of Pacific Biosciences of California, Inc. ( NASDAQ:PACB ) shareholders today, when...
ZacksPacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays
PacBio's (PACB) revenue growth in the first quarter is likely to have been hampered by an increasing number of customers delaying instrument purchases and softness in consumable shipments.
© 2024 Yahoo. All rights reserved.